Medical Prevention of Breast Cancer

被引：11
作者：
Stubert, Johannes [1 ]
Dieterich, Max [1 ]
Gerber, Bernd [1 ]
机构：
[1] Univ Rostock, Dept Obstet & Gynecol, D-18059 Rostock, Germany
来源：
BREAST CARE | 2014年 / 9卷 / 06期
关键词：
Breast cancer; Prevention; Tamoxifen; SERMs; Aromatase inhibitors; SURGICAL ADJUVANT BREAST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; BOWEL PROJECT; CLINICAL-TRIALS; FAMILY-HISTORY; FOLLOW-UP; RISK;
D O I：
10.1159/000369573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer is the most common cancer of women in Western Europe and North America. Effective strategies of medical prevention could reduce the burden of breast cancer mortality. The best evidence for a risk reduction exists for hormonal agents such as tamoxifen and raloxifene (22-72%) or aromatase inhibitors (50-65%). However, the severity of side effects and the lack of evidence for an improved survival compromise the risk/benefit balance. In this review the results of chemoprevention studies, including new treatment approaches, are summarized with critical discussion of their use in clinical practice.
引用
收藏
页码：391 / 396
页数：6
相关论文
共 50 条
  • [41] Hormonotherapy for breast cancer prevention: What about women with genetic predisposition to breast cancer?
    Senechal, Claire
    Reyal, Fabien
    Callet, Nasrine
    This, Pascale
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Fourme, Emmanuelle
    BULLETIN DU CANCER, 2016, 103 (03) : 273 - 281
  • [42] Breast cancer and osteoporosis
    Cheung, Angela M.
    Heisey, Ruth
    Srighanthan, Jeevitha
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2013, 20 (06) : 532 - 538
  • [43] Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference
    Stordal, Britta
    Harvie, Michelle
    Antoniou, Michael N.
    Bellingham, Michelle
    Chan, Doris S. M.
    Darbre, Philippa
    Karlsson, Oskar
    Kortenkamp, Andreas
    Magee, Pamela
    Mandriota, Stefano
    Silva, Elisabete
    Turner, James E.
    Vandenberg, Laura N.
    Evans, D. Gareth
    CANCER MEDICINE, 2024, 13 (18):
  • [44] Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent
    Ozdemir, Burcu Z.
    Goodin, Joel B.
    Bodenner, Donald L.
    BREAST CANCER-TARGETS AND THERAPY, 2019, 11 : 81 - 86
  • [45] Knowledge of medical school students on breast cancer and cervical cancer, and their prevention
    Liszcz, Anna
    Badowska-Kozakiewicz, Anna M.
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2015, 31 (04) : 271 - 276
  • [46] Breast Cancer and Osteoporosis - Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer
    Kalder, Matthias
    Hadji, Peyman
    BREAST CARE, 2014, 9 (05) : 312 - 317
  • [47] Personalized therapy for breast cancer
    De Abreu, F. B.
    Schwartz, G. N.
    Wells, W. A.
    Tsongalis, G. J.
    CLINICAL GENETICS, 2014, 86 (01) : 62 - 67
  • [48] Could the Women's Health Initiative Breathe New Life Into Breast Cancer Prevention?
    Ligibel, Jennifer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (13) : 1375 - +
  • [49] Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)
    Runowicz, Carolyn D.
    Costantino, Joseph P.
    Wickerham, Lawrence
    Cecchini, Reena S.
    Cronin, Walter M.
    Ford, Leslie G.
    Vogel, Victor G.
    Wolmark, Norman
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (06) : 535.e1 - 535.e5
  • [50] Endocrine Therapy for Primary and Secondary Prevention After Diagnosis of High-Risk Breast Lesions or Preinvasive Breast Cancer
    Laws, Alison
    Punglia, Rinaa S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17) : 3092 - +
12345